Conclusion WHO schema can be well applied to instruct clinical treatment and predict prognosis of thymoma.
结论WHO胸腺瘤组织分型方案能较好地指导临床治疗和判断预后,有较高的临床应用价值。
Is sacrifying the phrenic nerve during thymoma resection worthwhile?
胸腺切除术中牺牲膈神经是否值得?。
Objective To assess the effect of preoperative chemotherapy on invasive thymoma.
目的评价术前化疗在进展期恶性胸腺瘤治疗中的作用。
Objective: To study the ct features of thymoma and its value in clinical application.
前言:目的探讨胸腺瘤的CT表现及其临床应用价值。
Thymus pathology showed lymphoid hyperplasia 12 cases, normal 7 cases, no thymoma found.
胸腺病理检查:增生12例,正常组织学表现7例,无合并胸腺瘤者。
Objective To explore the significance of P53 protein expression in different type of thymoma.
目的探讨p53的表达在不同类型胸腺瘤中的意义。
Conclusion: TNF gene may be correlated with the susceptibility of thymoma and thymoma with MG.
结论TNF基因多态性与胸腺瘤发病及胸腺瘤发生重症肌无力相关。
Pathological classification of thymoma was in according to WHO2004 revised classification criteria.
胸腺瘤的病理分类根据WHO2004年修订后的分类标准。
Materials and Methods 19 patients with clinically-diagnosed thymoma scanned with multilayer spiral CT.
方法对19例临床诊断为胸腺瘤的患者进行多层螺旋CT扫描,并进行对照观察。
ResultsThe tumor included 4 invasive thymoma, 5 thymic cancer, 2 primary mediastinal small cell carcinoma.
结果侵袭性恶性胸腺瘤4例,胸腺癌5例,纵隔小细胞癌2例。
Malignant lymphoma 27, thymoma 23, teratoma 22, neurogenic tumor 20 and miscellaneous 18 cases were recorded.
恶性淋巴瘤27例,胸腺肿瘤23例,畸胎类肿瘤22例,神经源肿瘤20例,其它18例。
Objective To study thymoma specific associated antigen in citric acid extract of human skeletal muscle (CAE).
目的研究人骨骼肌柠檬酸提取物(CAE)中胸腺瘤特异相关抗原成份。
Type B2, B3 thymoma have obvious atypia with rich in euchromatin and distinct nucleolus in nuclei and broad cytoplasm with projections.
B3型胸腺瘤异型性较明显,常染色质较丰富,核仁明显,细胞质宽大,有突起。
Objective: to explore the clinical features of thymoma associated with pure red cell aplasia and to evaluate outcome of surgical treatment.
目的:探讨胸腺瘤合并单纯红细胞再生障碍性贫血的临床特征及治疗效果。
Methods:Fifty-seven cases of thymoma proved by surgery and pathology were examined with conventional CT, then the CT features were analysed.
方法对57例经手术及病理证实的胸腺瘤病人行常规CT检查,并对其CT表现进行分析。
Disease is found in any age, about 60% before the age of onset of 30, more common in women, and incidence were often accompanied by thymoma.
该病见于任何年龄,约60%在30岁以前发病,多见于女性,且发病者常伴有胸腺瘤。
Conclusion Metaplastic thymoma is a rarely encountered indolent or low-grade thymic tumor and may represent a distinct clinicopathologic entity.
结论化生性胸腺瘤是一类罕见的具有独特临床病理特征的良性或低度恶性胸腺上皮来源肿瘤。
Aim: to observe the clinical outcome of surgical treatment for malignant thymoma with myasthenia gravis (MG), and evaluate the prognostic factors.
目的:观察恶性胸腺瘤伴重症肌无力患者的临床疗效及预后影响因素。
Objective to study the clinicopathological and immunohistochemical features of ectopic hamartomatous thymoma (EHT), and to discuss its histogenesis.
目的探讨异位错构瘤性胸腺瘤的临床病理学特征、免疫学表型和组织发生。
Objective To characterize the clinical profiles and immunological findings in the first case of paraneoplastic pemphigus (PNP) complicated with thymoma in China.
目的报告我国首例伴发恶性胸腺瘤的副肿瘤性天疱疮(pnp)临床及免疫学特征。
Objective to explore the mechanism of human serum complement induced murine thymoma EL-4 cell lysis and to construct the complement non-lethal attack model on t lymphocytes.
目的探讨人血清补体杀伤小鼠胸腺瘤el - 4细胞的机制,建立补体杀伤t淋巴细胞的非致死模型。
Objective to analyze the electrophysiological characteristics in patients with myasthenia gravis (MG) and thymoma and to investigate the electrophysiological impacts of thymectomy.
目的探讨重症肌无力伴胸腺瘤及胸腺增生患者的电生理指标特点,并观察胸腺切除手术对于电生理指标的影响。
Methods the clinical data of 89 cases with myasthenia gravis were analyzed, 75 patients received drug treatment while the 14 patients complicated with thymoma received excision of thymoma.
方法分析89例重症肌无力临床资料,其中药物治疗75例,合并胸腺瘤者行胸腺瘤切除术14例。
Objective: To evaluate the X-ray and ct diagnostic value of Thymoma.
前言:目的:评价X线平片、CT对胸腺瘤的诊断价值。
Objective: To evaluate the X-ray and ct diagnostic value of Thymoma.
前言:目的:评价X线平片、CT对胸腺瘤的诊断价值。
应用推荐